As researchers race to develop a treatment for COVID-19, a new study out of New York has produced promising results with an unusual medication.
Doctors at Northwell Health want to know if a common, inexpensive heartburn drug, Pepcid, could offer a treatment for COVID-19. The study started a few weeks ago, but doctors at Northwell Health kept it under wraps until now to ensure their stockpile of Pepcid was large enough to conduct the trial.
"While it is a good heartburn medicine, its effect on virus is completely distant and separate," said Dr. David Battinelli, Northwell Health's Chief Medical Officer.